期刊文献+

黄芪提取物对局灶性脑缺血再灌注损伤的抗氧化及线粒体保护作用 被引量:41

Anti-oxidative and mitochondria-protective effects of extract of astragalus on focal cerebral ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的 研究黄芪提取物 (Extractofastragalus,EA)对局灶性脑缺血再灌注损伤大鼠的抗氧化及线粒体保护作用。方法 采用栓线法复制局灶性脑缺血 (MCAO)再灌注损伤模型,观察EA对大鼠脑组织匀浆中超氧化物歧化酶(SOD)、丙二醛(MDA)和乳酸 (LD)的影响;检测脑组织线粒体组分中的SOD、MDA含量及ATP酶活性的变化 ;电镜观察缺血再灌注后脑组织神经元超微结构的改变。结果 EA对大鼠MCAO2h再灌注 24h后脑组织及其线粒体组分中SOD活性的降低有明显的抑制作用,能抑制大鼠脑组织和脑组织线粒体组分中MDA含量的增加,能抑制大鼠脑组织LD含量的增加; EA可明显提高脑组织线粒体组分中Na+,K+ ATPase,Ca2+,Mg2+ ATPase活性;电镜照片显示EA组能改善脑组织神经元在脑缺血再灌注后的结构破坏情况。结论 EA对局灶性脑缺血再灌注损伤大鼠的保护作用的机制可能与其抗脂质过氧化和保护线粒体的作用有关。 Aim To study the anti-oxidative and mitochondria-protective effects of estract of astragalus (EA ) on focal cerebral ischemia-reperfusion injury and its mechanism in rats.Methods Middle cerebral artery occlusion(MACO) was used to induce focal cerebral ischemia-reperfusion model. After 24 h reperfusion,MDA, LD content and SOD activity of brain homogenate were tested. MDA content,SOD and ATPase activity in mitochondrion were also tested.Transmission electron microscopy was used to assess the ultrastructure dstruction. Results EA(20, 40, 80 mg·kg -1) significantly inhibited the increase of MDA, LD after cerebral ischemia-reperfusion. EA (40, 80 mg·kg -1) also inhibited the decrease of activit of SOD in rats. EA(20, 40, 80 mg·kg -1) inhibited the increase of MDA and inhibited the decrease of activities of SOD, Na+,K+-ATPase, Ca 2+,Mg 2+-ATPase in mitochondrion. The examination by transmission electron microscopy showed that EA (20, 40 mg·kg -1) protected the ultrastructure destruction. Conclusion EA had protective effects against focal cerebral ischemia reperfusion injuries via attenuating cerebral oxygen free radical(OFR)lipid peroxidation and protecting mitochondria.
出处 《中国药理学通报》 CAS CSCD 北大核心 2005年第2期216-219,共4页 Chinese Pharmacological Bulletin
基金 安徽省"十五"科技重点专项基金资助项目 (No01803016) 安徽省自然科学基金资助项目 (No00144414)
关键词 黄芪提取物 脑缺血再灌注 自由基 线粒体 extract of astragalus cerebral ischemia/reperfusion free radical mitochondrion
  • 相关文献

参考文献11

  • 1赵卫华,徐建兴,陈清棠.缺血再灌注期间大鼠脑线粒体的变化[J].中风与神经疾病杂志,2000,17(3):133-135. 被引量:5
  • 2张纬萍,魏尔清,朱朝阳,梅如焕,赵孟辉.大鼠局灶性脑缺血模型的定量分析[J].浙江大学学报(医学版),2002,31(2):72-76. 被引量:15
  • 3何婷,明亮,王绍斌,吴强,尹艳艳,李卫平.黄芪提取物对大鼠全脑缺血再灌注和小鼠缺氧性损伤的保护作用[J].中国药理学通报,2004,20(5):576-579. 被引量:16
  • 4王绍斌,李卫平,何婷,吴强,尹艳艳,明亮.黄芪提取物对全脑缺血损伤的保护作用[J].中国药理学通报,2004,20(3):338-342. 被引量:42
  • 5Koizumi JI, Yoshida Y, Nakazawa T et al.A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemia area[J]. Stroke,1986,8(1):1-8.
  • 6Longa EZ, Weinstein PR, Carlson S. Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
  • 7Piantadosi CA, Zhang J. Mitochondrial generation of reactive oxygen species after brain ischemia in the rat[J]. Stroke,1996,27(2):327-32.
  • 8Chan PH. Role of oxidants in ischemic brain damage[J].Stroke,1996,27(6):1124-9.
  • 9Barber DA, Hamis SR.oxygen free radicals and antioxidants:A review[J].Am Pharm,1994,34(9):26-35.
  • 10Renolleau S, Aggoun-Zouaoui D, Ben-Ari Y. A model of transient unilateral focal ischemia with reperfusion in the P7 neonatal rat: Morphological changes indicative of apoptosis[J].Stroke,1998,29(7):1451-61.

二级参考文献29

  • 1郭大海,徐建兴,古练权.两种新呼吸链抑制剂对心肌制剂抑制作用的比较[J].生物化学与生物物理进展,1993,20(6):446-452. 被引量:3
  • 2陈聪颖,陆阳,陈泽乃.内蒙黄芪的研究概况[J].中草药,2001,32(6):567-569. 被引量:37
  • 3叶春玲,李宝华.可乐定对小鼠和猫实验性脑缺血的保护作用[J].中国药理学与毒理学杂志,1993,7(1):42-44. 被引量:12
  • 4冯亦璞 孙亚丁 等.小鼠脑缺血后的能量代谢改变和药物的作用[J].药学学报,1989,24(2):89-94.
  • 5储国祥 陈修 见:徐叔云 卞如濂 陈修 主编.脑缺血实验方法[A].见:徐叔云、卞如濂、陈修,主编.药理实验方法学,第3版[C].北京:人民卫生出版社,2002.1061~2.
  • 6陈兴洲 见:张国瑾 赵增荣 主编.一氧化氮、一氧化氮合酶[A].见:张国瑾、赵增荣,主编.国外脑血管疾病研究进展[C].北京:中国医药科技出版社,2000.25~33.
  • 7Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989,20(1):84-91.
  • 8Belayev L, Ofelia F A, Raul B, et al. Middle cerebral artery occlusion in the rat by intraluminal suture [J]. Stroke, 1996,27(9):1616-1621.
  • 9Bederson J B, Pitts L H, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination [J]. Stroke, 1986,17(3):472-476.
  • 10Turgut T, Kentaro T, Richard A D C, et al. Delayed treatment with an adnenosine kinase inhibitor, GP683, attenuate infarct size in rats with temporary middle cerebral artery occlusion [J]. Stroke, 1998,29(9):1952-1958.

共引文献66

同被引文献492

引证文献41

二级引证文献337

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部